Webinar: The new EU HTA regulation and implications for European and national patient organisations and patients

April 16, 2024

Myeloma Patients Europe (MPE) and ALAN held a webinar on 22nd May 2024 on “The new EU Health Technology Assessment (HTA) regulation and implications for European and national patient organisations and patients”

What can you expect ?

The webinar provided an overview of the main provisions of the new EU HTA regulation with a focus on how these provisions will involve and impact patients, followed by a Q&A session with participants.

Speaker

The guest speaker was Béla Dajka, policy officer at the Directorate-General for Health and Food Safety in the European Commission. He is part of the team working on the implementation of the EU HTA regulation. Prior to this role, he oversaw EU support to national health systems for several EU countries. Béla studied journalism, media, management and health economics at universities in Russia, UK and USA. He worked at the BBC from 1998 to 2007 and joined the European Commission in 2008.

Recording: